Publication | Closed Access

Combination therapy using Smac peptide and doxorubicin-encapsulated MUC 1-targeted polymeric nanoparticles to sensitize cancer cells to chemotherapy: An in vitro and in vivo study

NanomedicineNanotherapeuticsEngineeringSmac PeptideMedicineTherapeutic NanomaterialsPolymer-drug ConjugatePharmacologyDrug Delivery SystemsNano-drug DeliveryCombination TherapyTumor TargetingBiomedical EngineeringCancer CellsOncology